SEC Form 4 · accession 0001209191-18-029508
U S PHYSICAL THERAPY INC /NV · USPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher J Reading
Officer — Chief Executive Officer · Director
Period of report
May 9, 2018
Accepted (ET)
May 11, 2018 · 3:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885978
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 9, 2018 | S | 13,639 | $92.01 | D | 89,828 | D | |
| Common StockF3,F2 | May 10, 2018 | S | 8,689 | $92.05 | D | 81,139 | D | |
| Common StockF4,F2 | May 11, 2018 | S | 2,672 | $92.16 | D | 78,467 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.00 - $92.10, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F2Includes 47,660 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 6,206 shares on each of July 1, 2018, October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022.
- F3The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.00 - $92.40, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F4The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.00 - $92.60, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.